Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,345 | 78,232 | 105,663 | 79,010 | 267,716 |
| Marketable Securities | 5,997 | 15,476 | 12,640 | 73,407 | N/A |
| Receivables | 6,587 | 3,253 | 4,250 | 3,362 | 7,412 |
| TOTAL | $50,929 | $96,961 | $122,553 | $155,779 | $275,128 |
| Non-Current Assets | |||||
| PPE Net | 3,808 | 4,048 | 4,274 | 4,976 | 9,307 |
| Investments And Advances | 0 | 0 | 0 | 9,440 | 0 |
| Intangibles | 45 | 53 | 62 | 72 | 88 |
| Other Non-Current Assets | 1,293 | 222 | 486 | 3,746 | 6,529 |
| TOTAL | $5,146 | $4,323 | $4,822 | $18,234 | $15,924 |
| Total Assets | $56,075 | $101,284 | $127,375 | $174,013 | $291,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,964 | 342 | 2,209 | 15,438 | 17,887 |
| Accrued Expenses | 11,160 | 7,802 | 9,479 | N/A | N/A |
| Other current liabilities | 167 | 164 | 13,320 | N/A | N/A |
| TOTAL | $13,613 | $8,462 | $25,293 | $15,624 | $17,985 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 114 | 632 | 405 | 0 | 0 |
| TOTAL | $482 | $656 | $585 | $897 | $810 |
| Total Liabilities | $14,095 | $9,118 | $25,878 | $16,521 | $18,795 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,521 | N/A | N/A | N/A | N/A |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -400,835 | -345,355 | -329,727 | -479,844 | -373,004 |
| Other shareholders' equity | -1,371 | -1,846 | -1,188 | 8,665 | 3,057 |
| TOTAL | $41,980 | $92,166 | $101,497 | $157,492 | $272,257 |
| Total Liabilities And Equity | $56,075 | $101,284 | $127,375 | $174,013 | $291,052 |